To characterize immune checkpoints in neurodegenerative diseases, we aimed to examine the expression of the immune checkpoint PD-1/PD-L1 in peripheral T cells in different Alzheimer’s disease (AD) patients. This evidence concerns the gene CD274 and early-onset autosomal dominant Alzheimer disease.